These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15328063)

  • 1. Effects of oral contraceptives on body composition and physical performance in female athletes.
    Rickenlund A; Carlström K; Ekblom B; Brismar TB; Von Schoultz B; Hirschberg AL
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4364-70. PubMed ID: 15328063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age at first oral contraceptive use as a major determinant of vertebral bone mass in female endurance athletes.
    Hartard M; Kleinmond C; Kirchbichler A; Jeschke D; Wiseman M; Weissenbacher ER; Felsenberg D; Erben RG
    Bone; 2004 Oct; 35(4):836-41. PubMed ID: 15454090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives improve endothelial function in amenorrheic athletes.
    Rickenlund A; Eriksson MJ; Schenck-Gustafsson K; Hirschberg AL
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3162-7. PubMed ID: 15769986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance.
    Lebrun CM
    Clin Sports Med; 1994 Apr; 13(2):419-41. PubMed ID: 8013042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral contraceptives on peak exercise capacity.
    Casazza GA; Suh SH; Miller BF; Navazio FM; Brooks GA
    J Appl Physiol (1985); 2002 Nov; 93(5):1698-702. PubMed ID: 12381756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral contraceptives on diurnal profiles of insulin, insulin-like growth factor binding protein-1, growth hormone and cortisol in endurance athletes with menstrual disturbance.
    Rickenlund A; Thorén M; Nybacka A; Frystyk J; Hirschberg AL
    Hum Reprod; 2010 Jan; 25(1):85-93. PubMed ID: 19840988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial.
    Meinhardt U; Nelson AE; Hansen JL; Birzniece V; Clifford D; Leung KC; Graham K; Ho KK
    Ann Intern Med; 2010 May; 152(9):568-77. PubMed ID: 20439575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives for the prevention of osteoporosis.
    Corson SL
    J Reprod Med; 1993 Dec; 38(12 Suppl):1015-20. PubMed ID: 8120858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density and history of oral contraceptive use.
    Fortney JA; Feldblum PJ; Talmage RV; Zhang J; Godwin SE
    J Reprod Med; 1994 Feb; 39(2):105-9. PubMed ID: 8169923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body composition of oligo/amenorrheic athletes.
    Carlberg KA; Buckman MT; Peake GT; Riedesel ML
    Med Sci Sports Exerc; 1983; 15(3):215-7. PubMed ID: 6621308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance.
    Rickenlund A; Carlström K; Ekblom B; Brismar TB; von Schoultz B; Hirschberg AL
    Fertil Steril; 2003 Apr; 79(4):947-55. PubMed ID: 12749436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low bone mineral density is two to three times more prevalent in non-athletic premenopausal women than in elite athletes: a comprehensive controlled study.
    Torstveit MK; Sundgot-Borgen J
    Br J Sports Med; 2005 May; 39(5):282-7; discussion 282-7. PubMed ID: 15849292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral contraceptives on weight and body composition in young female runners.
    Procter-Gray E; Cobb KL; Crawford SL; Bachrach LK; Chirra A; Sowers M; Greendale GA; Nieves JW; Kent K; Kelsey JL
    Med Sci Sports Exerc; 2008 Jul; 40(7):1205-12. PubMed ID: 18580398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
    Batzer FR
    J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of administration of monophasic oral contraceptive on the body composition and aerobic and anaerobic capacities of female athletes.
    Nakamura M; Nose-Ogura S
    J Obstet Gynaecol Res; 2021 Feb; 47(2):792-799. PubMed ID: 33336549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The physiology of the highly trained female endurance runner.
    Burrows M; Bird S
    Sports Med; 2000 Oct; 30(4):281-300. PubMed ID: 11048775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and fat patterning in young adult women.
    Litchfield RE; Grunewald KK
    Hum Biol; 1988 Oct; 60(5):793-800. PubMed ID: 3224970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise.
    Seeman E; Szmukler GI; Formica C; Tsalamandris C; Mestrovic R
    J Bone Miner Res; 1992 Dec; 7(12):1467-74. PubMed ID: 1481732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term postoperative oral contraceptive use for the prevention of endometrioma recurrence on bone mineral density in young women.
    Lee DY; Oh YK; Yoon BK; Choi D
    Gynecol Endocrinol; 2014 Oct; 30(10):751-4. PubMed ID: 24927075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.